Bio-Techne

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. 

CEO
Kim Kelderman
CEOKim Kelderman
Employees
3,100
Employees3,100
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
1976
Founded1976
Employees
3,100
Employees3,100

TECH Key Statistics

Market cap
9.90B
Market cap9.90B
Price-Earnings ratio
130.46
Price-Earnings ratio130.46
Dividend yield
0.50%
Dividend yield0.50%
Average volume
1.71M
Average volume1.71M
High today
$63.79
High today$63.79
Low today
$61.27
Low today$61.27
Open price
$63.78
Open price$63.78
Volume
1.39M
Volume1.39M
52 Week high
$79.28
52 Week high$79.28
52 Week low
$46.01
52 Week low$46.01

Stock Snapshot

The current Bio-Techne(TECH) stock price is $63.54, with a market capitalization of 9.9B. The stock trades at a price-to-earnings (P/E) ratio of 130.46 and offers a dividend yield of 50.1%.

During the trading session on 2025-12-04, Bio-Techne(TECH) shares reached a daily high of $63.79 and a low of $61.27. At a current price of $63.54, the stock is +3.7% higher than the low and still -0.4% under the high.

Trading volume for Bio-Techne(TECH) stock has reached 1.39M, versus its average volume of 1.71M.

Over the past 52 weeks, Bio-Techne(TECH) stock has traded between a high of $79.28 and a low of $46.01.

Over the past 52 weeks, Bio-Techne(TECH) stock has traded between a high of $79.28 and a low of $46.01.

TECH News

Simply Wall St 6d
Bio-Techne: Assessing Valuation After ACA Subsidy Extension Buzz Boosts Investor Sentiment

Investor sentiment around Bio-Techne (TECH) got a lift after news broke that the Trump administration may extend ACA subsidies for an additional two years. The...

Bio-Techne: Assessing Valuation After ACA Subsidy Extension Buzz Boosts Investor Sentiment

Analyst ratings

74%

of 19 ratings
Buy
73.7%
Hold
26.3%
Sell
0%

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.